1. Introduction {#sec1-children-05-00042}
===============

Asthma is the most common chronic disease in childhood, and the prevalence has increased considerably in recent decades \[[@B1-children-05-00042],[@B2-children-05-00042]\]. According to international guidelines, the ultimate goal of asthma management is to control the disease in terms of symptoms, pulmonary function, preventing asthma exacerbations and avoiding adverse effects from asthma medications. The main controller medications are inhaled corticosteroids that switch off the inflammation of asthmatic airways \[[@B3-children-05-00042],[@B4-children-05-00042]\].

Zinc (Zn) is a trace mineral involved in many functions in the body \[[@B5-children-05-00042]\]. Zn, an essential dietary metal, plays special roles in the conducting airways and contributes partly to the structure and function of many biological enzymes. It also regulates ion transporters relevant to pulmonary diseases \[[@B6-children-05-00042],[@B7-children-05-00042],[@B8-children-05-00042],[@B9-children-05-00042]\]. Zn is known to exhibit powerful antioxidant activity in the lungs and several body organs \[[@B6-children-05-00042],[@B7-children-05-00042],[@B8-children-05-00042],[@B9-children-05-00042]\]. Reactive oxygen species (ROS) have a role in initiating inflammation in asthmatic airways. Excessive ROS production in asthma leads to an oxidant-antioxidant imbalance in airways \[[@B10-children-05-00042]\]. It is possible that Zn deficiency can disturb the equilibrium between type 1 and type 2 T helpers, \[[@B11-children-05-00042]\] which leads to increased inflammation and eosinophilia. This is the same mechanism detected in allergic airway hypersensitivity \[[@B12-children-05-00042]\].

Chronic asthmatics take prophylactic inhaled steroids daily, which may have an important contributing effect on serum Zn status. Such a study has not been reported in the literature, but there are some studies that demonstrated a relationship between oral steroids and Zn levels in normal humans, asthmatic patients, burn patients, and patients with rheumatoid arthritis \[[@B13-children-05-00042],[@B14-children-05-00042],[@B15-children-05-00042]\].

The objective of our study was to measure the serum Zn level among asthmatic school children aged 7--14 years and to compare it to the serum Zn level in non-asthmatic children. The secondary objective was to investigate the association, if any, of Zn levels with the degree of asthma control and dosage of inhaled steroids.

2. Materials and Methods {#sec2-children-05-00042}
========================

2.1. Study Design and Population {#sec2dot1-children-05-00042}
--------------------------------

A cross-sectional study was conducted on 40 asthmatic school children attending the pediatric pulmonary clinics and 40 non-asthmatic school children from general pediatric clinics at Hamad Medical Corporation (HMC), Doha, Qatar, between January 2015 and May 2015. The following inclusion criteria for selecting asthmatic school children were used: (i) aged between 7 and 14 years and able to perform a spirometry and (ii) the diagnosis of asthma was based on a physician's diagnosis according to the American Thoracic Society (ATS) guidelines in accordance with guidelines of the Global Initiative for asthma and the International Study of Asthma and Allergies in Childhood(ISAAC) questionnaire \[[@B16-children-05-00042],[@B17-children-05-00042]\]. Asthma control was assessed using the Asthma Control Test (ACT) that includes five items (activity limitations, shortness of breath, nocturnal symptoms, rescue medication, and overall control in the past 4 weeks). Each item was scored from 1 (worst) to 5 (best). The ACT ranged from 5 to 25 (better indicated by higher values). A score of \>20 indicates well-controlled asthma, 16--19 partially controlled, and \<16 uncontrolled asthma \[[@B18-children-05-00042]\]. Healthy controls with matched age and gender (who dif not have recent or previous respiratory symptoms) were selected from the General pediatric clinic of the same hospital. Neither lung function or total IgE (immunoglobulin E) levels were measured for control subjects. We only measured the serum Zn level, hemoglobin, total protein and albumin concentrations for control subjects and then compared with the levels with those of asthma subjects. None of the subjects in either the asthmatic or control group had an acute respiratory infection for more than 4 weeks prior to enrollment. In addition, none of the asthmatic children had acute asthma exacerbation prior to enrollment. All subjects with significant advanced liver disease, diabetes mellitus those requiring insulin therapy, renal failure, malignancies, or collagen vascular disease or medications (both oral steroids and nonsteroidal anti-inflammatory drugs) were excluded from the study. In addition, we excluded all vegetarian subjects. This study was reviewed and approved by the local ethics committee at the Medical Research Center at HMC (Joint Institutional Review Board (JIRB), reviewed and approved on 23 October 2014; IRB Number: 14-00136). Written informed consent was obtained from the parents or guardians of the children and assent was obtained from children 9 years old and older.

2.2. Anthropometric Measurements {#sec2dot2-children-05-00042}
--------------------------------

Weight measurements were recorded using a digital electronic platform scale, and a standing height measurement without shoes was taken using a stadiometer. Body mass index (BMI) was calculated by dividing weight in kg by height squared in meters adjusted for age and gender. The standard deviation \[Z\] score for BMI was calculated.

Patients' spirometry tests were performed in the respiratory laboratory unit in accordance with the standards of the American Thoracic Society/European Respiratory Society task force: standardization of lung function testing \[[@B19-children-05-00042]\]. Spirometry was performed in patients old enough to perform this adequately. The highest of three appropriate measurements was recorded. Forced vital capacity (FVC; in liters and % predicted), forced expiratory volume in 1 s (FEV1; in liters and % predicted), and FEV1/FVC were measured using a flow-sensing spirometer (Sensor Medicus Model V6200, Hochberg, Germany.

2.3. Biochemical Analysis {#sec2dot3-children-05-00042}
-------------------------

Whole blood (5 mL) in a trace metal plain tube was collected from subjects (non-fasting blood sample) for measuring albumin, protein, hemoglobin and Zn. These measurements were determined by an atomic absorption spectrophotometer. An experienced senior laboratory technician performed the tests. Total IgE levels were measured in the school children with asthma.

2.4. Sample Size {#sec2dot4-children-05-00042}
----------------

An adequate sample was determined based on the primary outcome variables of the serum Zn level between asthmatic and healthy control groups. As per a literature review \[[@B20-children-05-00042],[@B21-children-05-00042]\], the mean Zn levels in asthmatic and healthy control groups were found to be 10.8 ± 2.5 μmol/L and 12.5 ± 1.8 μmol/L, respectively. With 90% power and at two-sided 0.05 level of significance, the required sample size was 35 patients in each group. To account for the proportion of dropouts and non-participation, 40 patients altogether were needed for enrollment.

2.5. Statistics {#sec2dot5-children-05-00042}
---------------

Categorical data are expressed as a frequency along with percentage and continuous data values presented as mean ± SD (standard deviation). Descriptive statistics summarized the demographic, BMI Z-score, serum zinc, spirometry measures and other characteristics of the participants. Association between two or more qualitative variables was analyzed using Chi-square or Fisher exact tests as appropriate. Unpaired *t*-tests compared the mean of quantitative variables between the two independent groups. The quantitative data mean across different degrees of asthma control (uncontrolled, partially controlled and controlled) was compared using one-way analysis of variance (ANOVA) and Kruskal Wallis tests as appropriate depending on the results of the normality test. Linear regression and Pearson's correlation coefficient were applied to estimate and assess the prediction and strength of the relationship between the Zn level and FEV1. A *p*-value of less than 0.05 was considered to be statistically significant. All statistical analyses were done using the statistical package SPSS 22 (SPSS Inc., Chicago, IL, USA).

3. Results {#sec3-children-05-00042}
==========

Eighty children including 40 asthmatic school children (aged 10.92 ± 1.81 years) and 40 matched non-asthmatic school children (aged 10.89 ± 1.87 years) were studied. Demographics, anthropometric characteristics and laboratory characteristics of asthmatic and healthy children are shown in [Table 1](#children-05-00042-t001){ref-type="table"}. Asthmatic and non-asthmatic groups were matched for age, gender, and BMI Z score (*p* \> 0.05). No significant difference was observed in Zn levels, albumin and total protein between both groups (*p* \> 0.05). Mean hemoglobin levels were noted to be significantly higher in the asthmatic group compared to the non-asthmatic group (*p* = 0.040). Our reference value for normal Zn levels was between 10.1--16.83 μmol/L according to the standard laboratory reference in our institution. The mean Zn level among asthmatic children was 12.78 ± 1.8 μmol/L, and four patients showed Zn deficiency. The mean serum Zn level among non-asthmatic children was 13.0 ± 1.52 μmol/L, one of which had a Zn deficiency. Among asthmatic children, Zn levels were not significantly associated with the degree of asthma control (well controlled, *n* = 17 patients; partially controlled, *n* = 15 patients and uncontrolled, *n* = 8 patients) (*p* \> 0.05) ([Figure 1](#children-05-00042-f001){ref-type="fig"}). All 40 asthmatic children performed spirometry tests, and the mean values observed for these parameters were FEV1% 84.9 ± 14.2, FVC% 92 ± 12, and FEV1/FVC 91.1 ± 8.7, respectively, and no significant correlation was found between the Zn level and FEV1% (Pearson correlation *r* = 0.220, *p* = 0.172), FVC% (*r* = 0.210, *p* = 0.194), and FEV1/FVC (*r* = 0.135, *p* = 0.405). All of the asthmatic children were taking inhaled steroids. The mean dosage of inhaled steroids did not differ among the different groups showing varying severity. The well-controlled asthma group had a mean dosage of 258.8 ± 134.9 μg/day, the partially controlled asthma group had a mean dosage of 310 ± 154.9 μg/day, and the uncontrolled group had a mean dosage of 243 ± 105.1 μg/day (*p* = 0.415). The mean total IgE value of the asthma group was 890.54 ± 1565.9 ku/L. There was no significant association observed between total IgE and Zn levels (*r* = − 0.082; *p* = 0.614).

4. Discussion {#sec4-children-05-00042}
=============

In the present study, we evaluated the Zn status in asthmatic school children. There was no difference in the mean serum Zn levels between asthmatic and non-asthmatic school children.

Zn is considered a gatekeeper of immune function and is important in immunological reactions such as the inflammatory response and the oxidative stress response \[[@B22-children-05-00042]\].

Hypozincemia was detected in four asthmatic children and in one child in the control group (statistically not significant). Zn deficiency has been suggested to play a role in the pathogenesis, control and severity of asthma because of its antioxidant, anti-apoptotic and anti-inflammatory effects in the respiratory epithelium. With respect to T cells, a disturbed ratio of Th1 and Th2 cells in favor of Th2-driven allergic reactions is a well-known consequence of Zn deficiency \[[@B23-children-05-00042]\]. Moreover, the pro-tolerogenic immunoreaction is triggered by long-lasting changes in intracellular Zn levels due to the induction of regulatory T cells and the dampening of pro-inflammatory Th17 and Th9 cells \[[@B24-children-05-00042]\].

Several studies reported conflicting relationship between Zn status and asthma. Similar to our finding, Kocyigit et al., reported plasma Zn, copper and albumin did not significantly differ in asthmatic children when compared to controls (*p* \> 0.05) \[[@B25-children-05-00042]\]. Other investigators found no significant decrease in Zn level in adult asthmatic patients \[[@B26-children-05-00042]\]. In addition, other investigators found no association between erythrocyte Zn levels and severity, duration of follow-up, and control of the asthma \[[@B27-children-05-00042]\]. In contrast to our findings, a number of investigators have reported that the serum Zn level tended to be lower in patients with bronchial asthma \[[@B13-children-05-00042],[@B20-children-05-00042],[@B21-children-05-00042],[@B28-children-05-00042],[@B29-children-05-00042]\]. In a study from Iran where Zn deficiency seems to be a common condition (a prevalence of 13.7% in healthy children), Zn deficiency appeared to have a significant role in asthma severity \[[@B28-children-05-00042]\]. Ghaffari J. et al. confirmed that administering Zn to asthmatic children with a low initial serum Zn produced significant improvements in clinical asthma symptoms and lung function \[[@B30-children-05-00042]\].

Various environmental factors, including individual characteristics such as age, gender and genetic predisposition, lifestyle-related factors, and nutrient-related factors such as dosage, route, duration of the exposure and the presence and variety of elements, affect the epigenome and are termed the "interactome". However, the interactome is difficult to estimate since drinking water and soil might contain different amounts of each trace element depending on the region \[[@B31-children-05-00042]\].

In the present study, we did not find an association between Zn levels and the degree of asthma control. This is in agreement with a previous study by Picado et al., who reported no association between either dietary intake or plasma/serum levels of micronutrients/antioxidants and asthma severity \[[@B32-children-05-00042]\].

All of the asthmatic school children were taking inhaled steroids. We found no significant association between Zn levels and the dose of inhaled steroids. A similar finding was reported by Goldey et al., who found no correlation between the serum Zn level and the use of steroids in asthmatic children \[[@B33-children-05-00042]\].

A study from Turkey reported low serum selenium, Zn and magnesium during acute asthma exacerbation, which increased after inhaled steroid treatment \[[@B34-children-05-00042]\]. In another study Raeve et al. showed that corticosteroids decreased oxidant levels by decreasing the number of oxidant-generating cells present in the asthmatic airway mucosa and reducing macrophage oxidant production \[[@B35-children-05-00042]\]. In contrast to these findings, several studies showed that the mean serum Zn level was lower in children using steroids compared to non-users \[[@B27-children-05-00042],[@B36-children-05-00042],[@B37-children-05-00042],[@B38-children-05-00042]\]. They suggested that steroids may increase urinary excretion of Zn-reducing serum, which would reduce the serum Zn level.

Although it has been found that hypo-zincemic allergic asthmatic patients had a higher mean total IgE, we did not find an association between Zn levels and IgE levels among our asthmatic children \[[@B36-children-05-00042]\].

The limitations in the present study are the low number of asthmatic school children, especially those with low Zn levels, resulting in a lack of generalizability of our findings to other (non Arab) populations, and the use of serum Zn is less accurate than evaluating the tissue Zn level. In addition, the present study did not assess confounding factors such as environmental tobacco that may affect the Zn levels or the association between Zn and lung function or asthma control.

5. Conclusions {#sec5-children-05-00042}
==============

Serum Zn may not play a major role in asthma control. However, further multicenter studies with greater sample sizes and adequate statistical power are required to prove the findings of the present study.
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![Laboratory characteristics among asthmatic children in relation to asthma control. IgE: Immunoglobulin E; Hb: hemoglobin, *p*---*p-*value.](children-05-00042-g001){#children-05-00042-f001}
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###### 

Demographics and laboratory results among cases and controls.

  Variable            Asthma          Non-Asthma      *p*-Value \*   
  ------------------- --------------- --------------- -------------- -------
  Age (years)         10.92 ± 1.807   10.89 ± 1.873   0.934          
  Gender              Male            34 (85%)        32 (80%)       0.556
  Female              6 (15%)         8 (20%)                        
  BMI Z scores        1.12 ± 1.35     0.92 ± 1.35     0.500          
  Hemoglobin (g/dL)   13.46 ± 1.07    12.98 ± 0.92    0.040 \*       
  Protein (g/L)       73.60 ± 4.48    73.23 ± 6.75    0.770          
  Albumin (g/L)       40.95 ± 2.87    42.93 ± 7.05    0.105          
  Zinc (μmol/L)       12.69 ± 1.80    13.0 ± 1.52     0.388          

BMI---Body mass index. Quantitative and qualitative values presented as the mean ± SD (standard deviation) and frequency along with %. \* Unpaired *t*-test and Chi-square *t*-test were used to compute the respective *p*-values.
